Tech Company M&A Transactions
Ception Therapeutics Acquisition
Ception Therapeutics, based in Malvern, was acquired by Cephalon. Financial terms set the valuation at $250 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/25/2010
Transaction Type
M&A
Amount
$250,000,000
M&A Terms
The deal was originally signed in early 2008, with Cephalon making a $100 million upfront payment, and agreeing to pay another $250 million if it chose to exercise the acquisition option.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Lindenwood Dr. 400
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
Ception Therapeutics is an emerging biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Tullman
Chief Financial Officer
Doug Gessl
Vice President
Jeffrey Wilkins
VP - Bus. Development
Kelly Copeland
VP - Operations
Evan Dick
VP - Product Management
Jeffrey Shaver
VP - R & D
Tim Henkel
VP - Regulatory Affairs
Patricia Cleveland
Browse more venture capital transactions:
Prev: 2/25/2010: DubLabs venture capital transaction
Next: 2/25/2010: MOG venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs